Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Bile Acid Metabolism-Based Integrative Subtyping Reveals CLCA1, UGT2A3, and ZG16 as Indicators of Immune Dysfunction and Adverse Outcomes in Colorectal Cancer

  • By

  • Li Feng

  • Min Wang

  • Xin Li

  • Long Wu

  • DeXin Gu

  • Bin Zhang

  • Peng Zheng

  • Qifeng Yang

  • Ke Wang

  • Gang Mao

  • August 27, 2026

Share

Clinical Scorecard: Correction: Bile Acid Metabolism-Based Integrative Subtyping Reveals CLCA1, UGT2A3, and ZG16 as Indicators of Immune Dysfunction and Adverse Outcomes in Colorectal Cancer

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Correction
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingOncology

Key Highlights

  • Identification of CLCA1, UGT2A3, and ZG16 as markers of immune dysfunction

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Provide relevant treatment information.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer

            • by Li Feng, Min Wang, Xin Li, Long Wu, DeXin Gu, Bin Zhang, Peng Zheng, Qifeng Yang, Ke Wang, Gang Mao

            • August 27, 2026

            Related Content

            Preoperative 18F-FDG PET/CT as a surgical triage tool for synchronous neoplasm detection in acute left-sided obstructive colorectal cancer: a two-institution retrospective cohort study

            Hepatectomy outperforms microwave ablation for colorectal cancer liver metastases, with anatomical location affecting ablation outcomes

            Retraction Note: Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway